VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib.
Fludarabine therapy in Waldenstr?m's macroglobulinemia.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fludarabine therapy in Waldenstr?m's macroglobulinemia.
Fludarabine therapy in Waldenstr?m's macroglobulinemia. Am J Med. 1993 Jul; 95(1):49-52.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Drug Administration Schedule
Female
Humans
Injections, Intravenous
Male
Middle Aged
Treatment Outcome
Vidarabine
Waldenstrom Macroglobulinemia
authors with profiles
HAGOP M KANTARJIAN